Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001789769-22-000012
Filing Date
2022-03-07
Accepted
2022-03-07 17:05:40
Documents
1
Period of Report
2022-03-04

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_164669070108181.html 4  
1 FORM 4 wf-form4_164669070108181.xml 4 4081
  Complete submission text file 0001789769-22-000012.txt   5452
Mailing Address 3963 MAPLE AVENUE SUITE 350 DALLAS TX 75219
Business Address 3963 MAPLE AVENUE SUITE 350 DALLAS TX 75219 (972) 499-3350
Instil Bio, Inc. (Issuer) CIK: 0001789769 (see all company filings)

EIN.: 832072195 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O INSTIL BIO, INC. 3963 MAPLE AVENUE, SUITE 350 DALLAS TX 75219
Business Address
Chiruvolu Vijay (Reporting) CIK: 0001851347 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40215 | Film No.: 22718892